Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV testing is not available, then individuals aged 25 to 65 years should be screened with cotesting (HPV testing in combination with cytology) every 5 years or cytology alone every 3 years (acceptable) (strong recommendation). The ACS recommends that individuals aged >65 years who have no history of cervical intraepithelial neoplasia grade 2 or more severe disease within the past 25 years, and who have documented adequate negative prior screening in the prior 10 years,…

• AC
  American Cancer Society
• BW
  Burroughs Wellcome Fund
• VF
  V Foundation for Cancer Research
• IF
  Impact Fund
• P
  Pfizer
• A
  AstraZeneca
• GS
  Gilead Sciences
• C
  Celgene
• HT
  Harvard T.H. Chan School of Public Health
• TT
  TG Therapeutics
• B
  BeiGene
• NI
  National Institutes of Health
• CF
  Centers for Disease Control and Prevention
• G
  Genentech
• P
  Pharmacyclics
• NC
  National Cancer Institute